abstract |
The present invention relates to a therapeutic agent for treating and / or preventing a disease associated with cells expressing CLD18, which comprises a tumor-related disease including gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, liver cancer, head and neck cancer, To provide useful antibodies.n n n n Claudin-18, cancer, monoclonal antibody |